Co-Authors
This is a "connection" page, showing publications co-authored by Robert Onyenwoke and Kevin Williams.
Connection Strength
0.903
-
Tarpley M, Oladapo H, Caligan TB, Onyenwoke RU, Williams KP. Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs. Data Brief. 2021 Aug; 37:107189.
Score: 0.200
-
Tarpley M, Caligan TB, Onyenwoke RU, Williams KP. Optimization and validation of a DYRK1A TR-FRET assay for high-throughput screening. MethodsX. 2021; 8:101383.
Score: 0.199
-
Tarpley M, Oladapo HO, Strepay D, Caligan TB, Chdid L, Shehata H, Roques JR, Thomas R, Laudeman CP, Onyenwoke RU, Darr DB, Williams KP. Identification of harmine and ?-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. Eur J Pharm Sci. 2021 Jul 01; 162:105821.
Score: 0.197
-
Ehe BK, Lamson DR, Tarpley M, Onyenwoke RU, Graves LM, Williams KP. Data on peptides identified by mass spectrometry analysis of in vitro DYRK1A-mediated phosphorylation sites on GLI1. Data Brief. 2017 Dec; 15:577-583.
Score: 0.155
-
Ehe BK, Lamson DR, Tarpley M, Onyenwoke RU, Graves LM, Williams KP. Identification of a DYRK1A-mediated phosphorylation site within the nuclear localization sequence of the hedgehog transcription factor GLI1. Biochem Biophys Res Commun. 2017 09 23; 491(3):767-772.
Score: 0.153